Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic ...

The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

Zydus Lifesciences has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture ...

HART Hub funding – to establish a Homelessness and Addiction Recovery Treatment hub in Sault Ste. Marie — is vital to help ...

Three people are facing charges after police say they were part of a drug and gun trafficking scheme. According to United ...

On September 3, OBX-115, a novel TIL therapy, was granted FDA regenerative medicine advanced therapy (RMAT) designation in ...

Researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to ...

Sanyou Bio recently celebrated a prestigious move into its new 10,000-square-meter R&D building at Shanghai headquarters.

Those data were part of the application that ... to other uses of the drug in other conditions as well. “Neuropsychiatry is at the cusp of bringing an explosion of new medicines, and Cobenfy ...

Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...